Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Patient demographics 11
1.3 Healthcare Spending in the US 14
1.4 Definition: Prosthetic Valve 14
1.5 Why prosthetic valve? 14
1.6 Selection criteria for prosthetic heart valve 15
1.7 Industry Trends 15
2 Report Outline 16
2.1 Report Scope 16
2.2 Report Summary 17
2.3 Research Methodology 18
2.4 Report Assumptions 18
3 Market Snapshot 19
3.1 Total Addressable Market (TAM) 19
3.2 Segmented Addressable Market (SAM) 21
3.3 Porter 5 (Five) Forces 24
4 Market Dynamics 25
4.1.1 Drivers 26
4.1.1.1 Increasing prevalence of cardiovascular diseases 26
4.1.1.2 Increasing geriatric population 26
4.1.1.1 Increase in healthcare spending 26
4.1.1.2 Increasing number of insurance providers 26
4.1.2 Restraints 27
4.1.2.1 Risk associated with prosthetic valves 27
4.1.2.2 Stringent regulations for approval 27
4.1.2.3 Intense competition among vendors 27
4.1.2.4 Lack of awareness 28
4.1.3 Opportunities 28
4.1.3.1 Technological advancement 28
4.1.3.2 Increase demand or minimally invasive procedures 28
4.1.3.3 Increase in demand for cardiac diagnostic imaging 29
4.1.3.4 5.2.1.2 Increase in the number of outpatient procedures 29
4.1.3.5 Growth opportunities in emerging nations 29
4.1.4 DRO - Impact Analysis 30
4.1.5 Key Stakeholders 31
5 Product Types: Market Size & Analysis 32
5.1 Overview 32
5.2 Transcatheter heart valve 35
5.2.1 Overview 35
5.3 Mechanical Heart Valve 36
5.3.1 Overview 36
5.4 Tissue or Bio-prosthetic heart valve 37
5.4.1 Overview 37
6 End-user: Market Size and Analysis 40
6.1 Overview 40
6.2 Hospitals 40
6.3 Ambulatory Surgical Center 41
6.3.1 ASCs in the Americas 42
6.3.1.1 US 42
6.3.1.2 Canada 42
6.3.1.3 Mexico 42
6.3.2 ASCs in the EMEA Region 42
6.3.2.1 France 42
6.3.2.2 UK 42
6.3.2.3 Israel 42
6.3.2.4 Africa 42
6.3.3 ASCs in the APAC Region 43
6.3.3.1 Australia 43
6.3.3.2 India 43
6.3.3.3 China 43
6.4 Cardiac Centers 43
7 Regions: Market Size & Analysis 45
7.1 Overview 45
7.2 North America 46
7.2.1 Market Overview 46
7.3 Europe 47
7.3.1 Market Overview 47
7.4 APAC 49
7.4.1 Market Overview 49
7.4.2 Japan 50
7.4.3 China 50
7.4.4 India 50
7.5 Rest of the World 51
7.5.1 Market Overview 51
8 Competitive Landscape 55
8.1 Competitor Comparison Analysis 55
9 Vendor Profiles 56
9.1 Abbott Laboratories 56
9.1.1.1 Overview 56
9.1.2 Overview 56
9.1.3 Business Unit 59
9.1.4 Geographic Presence 60
9.1.5 Business Focus 60
9.1.6 SWOT Analysis 61
9.1.7 Business Strategy 61
9.2 Boston Scientific Corp 62
9.2.1 Overview 62
9.2.2 Business Units 64
9.2.3 Geographic Presence 65
9.2.4 Business Focus 66
9.2.5 SWOT Analysis 67
9.2.6 Business Strategy 67
9.3 Medtronic Plc 68
9.3.1 Overview 68
9.3.2 Business Units 75
9.3.3 Geographic Presence 76
9.3.4 Business Focus 77
9.3.5 SWOT Analysis 78
9.3.6 Business Strategies 78
9.4 Edward Lifesciences Corp 79
9.4.1.1 Overview 79
9.4.1.2 Business unit 81
9.4.1.3 Business focus 82
9.4.1.4 SWOT analysis 82
9.4.1.5 Business strategies 84
9.5 LivaNova' PLC (Sorin Group) 85
9.5.1 Overview 85
9.5.2 Business Units 87
9.5.3 Geographic Presence 88
9.5.4 Business Focus 89
9.5.5 SWOT Analysis 89
9.5.6 Business Strategy 89
10 Companies to watch for 90
10.1 Cryolife' Inc. 90
10.1.1 Overview 90
10.1.2 Key Highlights 90
10.1.3 Business Strategies 90
10.2 Lepu Medical Technology Co.' Ltd. 91
10.2.1 Overview 91
10.2.2 Key Highlights 91
10.2.3 Business Strategies 91
10.3 Colibri Heart Valve LLC 92
10.3.1 Key Highlights 93
10.3.2 Business Strategies 93
10.4 JenaValve Technology GmbH 94
10.5 TTK Healthcare Ltd. 94
10.5.1 Overview 94
10.6 ValveXchange Inc. 95
10.6.1 Overview 95
Annexure 96
> Acronyms 96